These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Microarray-based analysis of spinal versus intracranial meningiomas: different clinical, biological, and genetic characteristics associated with distinct patterns of gene expression. Sayagués JM; Tabernero MD; Maíllo A; Trelles O; Espinosa AB; Sarasquete ME; Merino M; Rasillo A; Vera JF; Santos-Briz A; de Alava E; Garcia-Macias MC; Orfao A J Neuropathol Exp Neurol; 2006 May; 65(5):445-54. PubMed ID: 16772868 [TBL] [Abstract][Full Text] [Related]
26. Genetic/molecular alterations of meningiomas and the signaling pathways targeted. Domingues P; González-Tablas M; Otero Á; Pascual D; Ruiz L; Miranda D; Sousa P; Gonçalves JM; Lopes MC; Orfao A; Tabernero MD Oncotarget; 2015 May; 6(13):10671-88. PubMed ID: 25965831 [TBL] [Abstract][Full Text] [Related]
27. Genomic Biomarkers of Meningioma: A Focused Review. Pawloski JA; Fadel HA; Huang YW; Lee IY Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638590 [TBL] [Abstract][Full Text] [Related]
28. Expression of the tumor suppressor genes NF2, 4.1B, and TSLC1 in canine meningiomas. Dickinson PJ; Surace EI; Cambell M; Higgins RJ; Leutenegger CM; Bollen AW; LeCouteur RA; Gutmann DH Vet Pathol; 2009 Sep; 46(5):884-92. PubMed ID: 19429976 [TBL] [Abstract][Full Text] [Related]
29. Decoding the Role of DVL1 in Intracranial Meningioma. Bukovac A; Dragičević K; Kafka A; Orešković D; Cesarec-Augustinović S; Pećina-Šlaus N Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769425 [TBL] [Abstract][Full Text] [Related]
30. Sarcomatous Meningioma: Diagnostic Pitfalls and the Utility of Molecular Testing. Lucas CG; Devine P; Solomon DA; Giannini C; Reifenberger G; Dahiya S; Caccamo D; Perry A J Neuropathol Exp Neurol; 2021 Sep; 80(8):764-768. PubMed ID: 34128073 [TBL] [Abstract][Full Text] [Related]
31. Alterations of oxidative phosphorylation in meningiomas and peripheral nerve sheath tumors. Feichtinger RG; Weis S; Mayr JA; Zimmermann FA; Bogner B; Sperl W; Kofler B Neuro Oncol; 2016 Feb; 18(2):184-94. PubMed ID: 26106125 [TBL] [Abstract][Full Text] [Related]
32. Genomic and transcriptome analysis revealing an oncogenic functional module in meningiomas. Chang X; Shi L; Gao F; Russin J; Zeng L; He S; Chen TC; Giannotta SL; Weisenberger DJ; Zada G; Wang K; Mack WJ Neurosurg Focus; 2013 Dec; 35(6):E3. PubMed ID: 24289128 [TBL] [Abstract][Full Text] [Related]
33. PDGF activation in PGDS-positive arachnoid cells induces meningioma formation in mice promoting tumor progression in combination with Nf2 and Cdkn2ab loss. Peyre M; Salaud C; Clermont-Taranchon E; Niwa-Kawakita M; Goutagny S; Mawrin C; Giovannini M; Kalamarides M Oncotarget; 2015 Oct; 6(32):32713-22. PubMed ID: 26418719 [TBL] [Abstract][Full Text] [Related]
34. Functional significance of S6K overexpression in meningioma progression. Surace EI; Lusis E; Haipek CA; Gutmann DH Ann Neurol; 2004 Aug; 56(2):295-8. PubMed ID: 15293284 [TBL] [Abstract][Full Text] [Related]
35. Histological classification and molecular genetics of meningiomas. Riemenschneider MJ; Perry A; Reifenberger G Lancet Neurol; 2006 Dec; 5(12):1045-54. PubMed ID: 17110285 [TBL] [Abstract][Full Text] [Related]
36. The transmembrane chemokines CXCL16 and CX3CL1 and their receptors are expressed in human meningiomas. Li G; Hattermann K; Mentlein R; Mehdorn HM; Held-Feindt J Oncol Rep; 2013 Feb; 29(2):563-70. PubMed ID: 23229614 [TBL] [Abstract][Full Text] [Related]
37. Differential expression of extracellular matrix-related genes in rare variants of meningioma. Kwon MJ; Sung CO; Kang SY; Do IG; Suh YL Hum Pathol; 2013 Feb; 44(2):260-8. PubMed ID: 22995327 [TBL] [Abstract][Full Text] [Related]